Emerging Trends in Reproductive Endocrinology and Pregnancy-Related Disorders

Dear Colleagues, 

Pregnancy-related disorders, such as preeclampsia, eclampsia, gestational diabetes, and the complex management of multiple pregnancies, continue to pose significant risks to maternal and neonatal health worldwide. This Special Issue aims to highlight the pressing need for advanced research in the field of reproductive endocrinology and obstetric pathophysiology. Emphasis is placed on the development and integration of innovative diagnostic and therapeutic strategies to enhance early detection and personalized management of these conditions. State-of-the-art molecular and imaging technologies—such as OMICs platforms (genomics, proteomics, metabolomics) and advanced imaging—are rapidly transforming the clinical landscape, offering promising avenues for improved outcomes.

A multidisciplinary approach involving obstetrics, endocrinology, molecular biology, medical genetics, and bioinformatics is essential to elucidate the complex etiologies and pathophysiological mechanisms underlying pregnancy-related disorders. Moreover, the incorporation of precision medicine and personalized therapeutic protocols, tailored to the genetic and biochemical profile of each patient, is becoming increasingly vital. The potential application of artificial intelligence and machine learning in optimizing clinical decision-making and predicting adverse maternal–fetal outcomes further underscores the necessity of integrating cutting-edge technology into maternal care.

We warmly welcome submissions from reproductive endocrinologists, maternal–fetal medicine specialists, molecular biologists and geneticists, pharmacologists, and researchers working in related fields to contribute their original research articles and reviews. We also encourage interdisciplinary collaborations that bridge basic science and clinical applications in pregnancy-related disorders and reproductive endocrinology.

Dr. Theodoros Kalampokas
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.